Wellington Management Group’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$182M Sell
3,409,946
-2,526,294
-43% -$135M 0.03% 377
2025
Q1
$240M Sell
5,936,240
-1,440,721
-20% -$58.3M 0.05% 305
2024
Q4
$205M Sell
7,376,961
-519,671
-7% -$14.5M 0.04% 362
2024
Q3
$227M Buy
7,896,632
+2,782,029
+54% +$79.8M 0.04% 364
2024
Q2
$120M Sell
5,114,603
-98,761
-2% -$2.32M 0.02% 500
2024
Q1
$132M Buy
5,213,364
+2,331,375
+81% +$58.9M 0.02% 491
2023
Q4
$67.3M Buy
2,881,989
+2,053,028
+248% +$47.9M 0.01% 645
2023
Q3
$41.9M Sell
828,961
-72,244
-8% -$3.65M 0.01% 736
2023
Q2
$42.1M Sell
901,205
-259,337
-22% -$12.1M 0.01% 754
2023
Q1
$44.4M Buy
1,160,542
+284,443
+32% +$10.9M 0.01% 719
2022
Q4
$48M Buy
876,099
+79,600
+10% +$4.36M 0.01% 694
2022
Q3
$27.1M Buy
796,499
+94,019
+13% +$3.2M 0.01% 828
2022
Q2
$6.64M Sell
702,480
-1,530,043
-69% -$14.5M ﹤0.01% 1228
2022
Q1
$31.7M Buy
2,232,523
+355,712
+19% +$5.05M 0.01% 893
2021
Q4
$39.7M Sell
1,876,811
-30,517
-2% -$645K 0.01% 898
2021
Q3
$42.6M Buy
1,907,328
+257,638
+16% +$5.76M 0.01% 867
2021
Q2
$40.9M Buy
1,649,690
+106,360
+7% +$2.64M 0.01% 884
2021
Q1
$44.8M Sell
1,543,330
-127,180
-8% -$3.69M 0.01% 830
2020
Q4
$43.1M Sell
1,670,510
-121,803
-7% -$3.14M 0.01% 807
2020
Q3
$55.2M Buy
1,792,313
+1,784,115
+21,763% +$54.9M 0.01% 671
2020
Q2
$204K Buy
+8,198
New +$204K ﹤0.01% 1805
2020
Q1
Sell
-246,301
Closed -$5.47M 1898
2019
Q4
$5.47M Sell
246,301
-21,766
-8% -$483K ﹤0.01% 1314
2019
Q3
$6.1M Sell
268,067
-64,093
-19% -$1.46M ﹤0.01% 1291
2019
Q2
$6.36M Buy
+332,160
New +$6.36M ﹤0.01% 1320